← Back to headlines
Krystal Biotech Joins S&P MidCap 400
Krystal Biotech has been added to the S&P MidCap 400 index, while TMHC and AVNS have been removed.
20 Jul, 22:06 — 20 Jul, 22:06
Sources
Showing 1 of 1 sources
Krystal Biotech has been added to the S&P MidCap 400 index, while TMHC and AVNS have been removed.
